Cetera Advisor Networks’s Mustang Bio MBIO Stock Holding History

Cetera Advisor Networks’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-24	Closed	-$6.53K	–	2670
2023 Q1	$6.53K	Sell	24 -46	-66%	-$18.9K	﹤0.01%	2566
2022 Q4	$20.6K	Hold	70	–	–	﹤0.01%	2483
2022 Q3	$25K	Hold	70	–	–	﹤0.01%	2043
2022 Q2	$31K	Buy	+70	New	+$38.8K	﹤0.01%	2023

Other funds holding MBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cetera Advisor Networks's MBIO Position: Q2 2023 in Review

Cetera Advisor Networks sold out of Mustang Bio (MBIO) in Q2 2023, closing a stake of 24 shares — an estimated $6.53K sold.

Cetera Advisor Networks first reported a position in MBIO in Q2 2022 and held it in 4 quarters. The position peaked at $31K in Q2 2022. 27 funds tracked by Wall St. Rank hold MBIO as of Q2 2023.

Cetera Advisor Networks reported no remaining Mustang Bio position as of Q2 2023 after selling out during the quarter.
Cetera Advisor Networks sold 24 Mustang Bio shares in Q2 2023, an estimated $6.53K.
Cetera Advisor Networks first reported a position in Mustang Bio in Q2 2022 and held it in 4 quarters.
Cetera Advisor Networks's Mustang Bio position peaked at $31K in Q2 2022.
27 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2023.

Based on Cetera Advisor Networks's 13F filing for Q2 2023, filed 10 Aug 2023.